Optical biomarkers of serous and mucinous human ovarian tumor assessed with nonlinear optics microscopies.
A Case of Ovarian Seromucinous Borderline Tumor With a Predominant Serous Component Suggesting Serous Borderline Tumor With Mucinous Differentiation.
The MRI findings in a case of ovarian mucinous borderline tumor mimicking a serous surface borderline tumor.
Giant Mucinous Borderline Ovarian Tumor Presenting Alongside Perforated Peptic Ulcers.
Pence S, Christiansen A, George E.
J Obstet Gynaecol Can. 2024 Mar;46(3):102114. doi: 10.1016/j.jogc.2023.04.005. Epub 2023 Apr 13.
Serous and mucinous borderline ovarian tumours: differences in clinical presentation, high-risk histopathological features, and lethal recurrence rates.
Vasconcelos I, Darb-Esfahani S, Sehouli J.
BJOG. 2016 Mar;123(4):498-508. doi: 10.1111/1471-0528.13840. Epub 2015 Dec 25.
A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas.
Basturk O, Hong SM, Wood LD, Adsay NV, Albores-Saavedra J, Biankin AV, Brosens LA, Fukushima N, Goggins M, Hruban RH, Kato Y, Klimstra DS, Klöppel G, Krasinskas A, Longnecker DS, Matthaei H, Offerhaus GJ, Shimizu M, Takaori K, Terris B, Yachida S, Esposito I, Furukawa T; Baltimore Consensus Meeting.
Am J Surg Pathol. 2015 Dec;39(12):1730-41. doi: 10.1097/PAS.0000000000000533.
Calcifications in mucinous and serous cystic ovarian tumors.
Okada S, Ohaki Y, Inoue K, Kawamura T, Hayashi T, Kato T, Kumazaki T.
J Nippon Med Sch. 2005 Feb;72(1):29-33. doi: 10.1272/jnms.72.29.
The Epithelial-Mesenchymal Transition, E-cadherin and Tumor Progression in Ovarian Serous Tumors.
Bozhkova DM, Poryazova-Markova EG.
Folia Med (Plovdiv). 2019 Jun 1;61(2):296-302. doi: 10.2478/folmed-2018-0082.
Genetic analysis for mucinous ovarian carcinoma with infiltrative and expansile invasion and mucinous borderline tumor: a retrospective analysis.
Hada T, Miyamoto M, Ohtsuka Y, Suminokura J, Ito T, Kishimoto N, Nishitani S, Takada M, Imauji A, Tanabe R, Takano M.
Diagn Pathol. 2023 Apr 20;18(1):49. doi: 10.1186/s13000-023-01340-w.
High grade serous ovarian carcinomas originate in the fallopian tube.
Labidi-Galy SI, Papp E, Hallberg D, Niknafs N, Adleff V, Noe M, Bhattacharya R, Novak M, Jones S, Phallen J, Hruban CA, Hirsch MS, Lin DI, Schwartz L, Maire CL, Tille JC, Bowden M, Ayhan A, Wood LD, Scharpf RB, Kurman R, Wang TL, Shih IM, Karchin R, Drapkin R, Velculescu VE.
Nat Commun. 2017 Oct 23;8(1):1093. doi: 10.1038/s41467-017-00962-1.
Association between pelvic inflammatory disease, infertility, ectopic pregnancy and the development of ovarian serous borderline tumor, mucinous borderline tumor and low-grade serous carcinoma.
Stewart LM, Stewart CJR, Spilsbury K, Cohen PA, Jordan S.
Gynecol Oncol. 2020 Mar;156(3):611-615. doi: 10.1016/j.ygyno.2020.01.027. Epub 2020 Jan 23.
Serous and mucinous borderline (low malignant potential) tumors of the ovary.
Acs G.
Am J Clin Pathol. 2005 Jun;123 Suppl:S13-57. doi: 10.1309/J6PXXK1HQJAEBVPM.
L1-CAM in Mucinous Ovarian Carcinomas and Borderline Tumors: Impact on Tumor Recurrence and Potential Role in Tumor Progression.
Wiedenhoefer R, Schmoeckel E, Grube M, Sulyok M, Pasternak I, Beschorner C, Greif K, Brucker S, Mayr D, Kommoss S, Fend F, Staebler A, Fischer AK.
Am J Surg Pathol. 2023 May 1;47(5):558-567. doi: 10.1097/PAS.0000000000002027. Epub 2023 Feb 28.
